Physician profile
Nicholas Steier
NPI 1174673172
$5,141.55
in general payments reported to CMS, 2019-2025
42 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,794 · 2020: $848 · 2021: $1,368 · 2022: $101 · 2023: $313 · 2024: $298 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.78 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $811.60 | 2019-2025 | Airsupra, Breztri |
| Amgen INC. | $581.63 | 2019-2025 | Evenity, Prolia |
| Novo Nordisk INC | $489.55 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $439.25 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $373.46 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.97 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $343.73 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $225.48 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $184.82 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $171.35 | 2019-2023 | |
| Glaxosmithkline, LLC. | $132.33 | 2019-2024 | Trelegy Ellipta |
| Esperion Therapeutics, INC. | $108.35 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $84.18 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $79.50 | 2021 | |
| Amarin Pharma, INC. | $63.24 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Steier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.